This is an impromptu interview that took place this Sept 11 2021 on the ClubHouse audio platform. It is reproduced here with permission. Prof. Cahill presents her perspectives on issues such as the potential risks, short and long term, associated with injections, including ADE & prion disease. Questions associated with the delta variant are then discussed. Also, potential risks for the elderly in aged care facilities are discussed, so are the potential risks for children and young adults - given the particularly low C19 risks for that age group. Throughout the interview, the key role of early outpatient treatment is being stressed. The interview ends with a discussion of the role of the World Doctors Alliance, of which Prof. Cahill is a past president. This interview is presented only for information purposes. For therapeutic advice, please consult your doctor or health care provider. And for sure, you need to consult other perspectives before making any decisions in relation with this particularly sensitive topic. Dolores Cahill, PhD, is Professor at the University College Dublin since 2005. She was previously a group leader at the Max-Planck-Institute in Berlin. She is an Inventor, Founder and Shareholder of Companies, has been granted & licensed Patents in Europe, USA & worldwide with applications in improving the early accurate diagnosis of disease (auto immune diseases & cancer). For more details about her extensive career, please visit Prof. Cahill's website at: https://dolorescahill.com